Klinikum der Universitaet Muenchen, Grosshadern: Clinical Trials

11 trials sponsored by Klinikum der Universitaet Muenchen, Grosshadern, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown, 1 terminated. 3 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1
Not applicable2Completed 1, Unknown 1
Phase 32Unknown 2
Phase 41Completed 1

Follow Klinikum der Universitaet Muenchen, Grosshadern: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inspired Oxygen on Oxidative Stress and Breath Volatile Organic Compound Composition in Healthy Volunteers
Oxygen, Ambient - Oxidative Stress
Not applicableUnknownKlinikum der Universitaet Muenchen, Grosshadern202016-05-012018-03-08
Evaluation of Votrient in Angiosarcoma
Pazopanib + Paclitaxel - Angiosarcoma
Phase 2TerminatedHeidelberg University262014-07-012022-03-22
Exercise Training After Transcatheter Aortic Valve Implantation
Exercise - Transcatheter Aortic Valve Replacement
Not applicableCompletedTechnical University of Munich302013-06-012015-01-26
Non-invasive Optical Detection of Iron Deficiency
Not an interventional study - Anemia, Iron-Deficiency
CompletedKlinikum der Universitaet Muenchen, Grosshadern962013-06-012015-04-08
Hyperthermia European Adjuvant Trial
Gemcitabine + Cisplatin + regional hyperthermia, Gemcitabine + Capecitabine - Resected Pancreatic Adenocarcinoma
Phase 3UnknownKlinikum der Universitaet Muenchen, Grosshadern3362012-03-012017-11-17
Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort
Stroke
UnknownCharite University, Berlin, Germany7502010-02-012011-06-02
Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL
Rituximab, High dose Ara-C, Dexamethasone - Mantle Cell Lymphoma
Phase 3UnknownProf. Dr. M. Dreyling (co-chairman)1282009-05-092017-03-07
Comparison of Ultrasound Versus Radiography for Diagnosis of Nasal Fractures
Nasal Fracture
CompletedKlinikum der Universitaet Muenchen, Grosshadern802008-03-012009-04-21
Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia
Bortezomib, Dexamethasone, Rituximab - Waldenstroms Macroglobulinemia
Phase 2CompletedEuropean Myeloma Network B.V.592006-09-012015-02-18
Efficacy of Local Overpressure Treatment for Meniere's Disease
Meniett(C) device by MedTronic, placebo treatment - Meniere's Disease
Phase 4CompletedKlinikum der Universitaet Muenchen, Grosshadern802005-08-012009-04-21
Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)
Cyclophosphamide, Pentostatin, Rituximab - Immunocytoma/Morbus Waldenström, B-Cell Non-Hodgkin's Lymphoma
Phase 2UnknownHeidelberg University1852005-02-012009-06-25

Conditions studied

Anemia, Iron-Deficiency (1)  ·  Hemangiosarcoma (1)  ·  Hyperthermia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Meniere Disease (1)  ·  Pancreatic Neoplasms (1)  ·  Recurrence (1)  ·  Stroke (1)  ·  Vertigo (1)  ·  Waldenstrom Macroglobulinemia (1)

Interventions

Rituximab (3)  ·  Bortezomib (2)  ·  Dexamethasone (2)  ·  Capecitabine (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Exercise (1)  ·  Gemcitabine (1)  ·  Oxygen (1)  ·  Paclitaxel (1)  ·  Particulate Matter (1)  ·  Pentostatin (1)  ·  Transtympanic Micropressure Treatment (1)  ·  pazopanib (1)

Countries

Germany (9)  ·  Austria (1)  ·  France (1)  ·  Greece (1)

Top investigators

Anthony D Ho, Ph.D., Prof. (1)  ·  Axel Pressler, MD (1)  ·  Eike Krause, MD (1)  ·  Martin Dreyling, MD (1)  ·  Meletios A Dimopoulos, MD (1)  ·  Michael E Dolch, MD (1)  ·  Peter Hohenberger, MD (1)  ·  Peter U Heuschmann, MD MPH (1)  ·  Rolf D. Issels, MD, PhD (1)  ·  Uwe Hasbargen, PD Dr. med. (1)

Results publications

PMID 22928669, PMID 27914499, PMID 29553289, PMID 31526121, PMID 32279621, PMID 33184230, PMID 33982599, PMID 36247749, PMID 36657324, PMID 37848651, PMID 38014691, PMID 38678093, PMID 40620229, PMID 41057606, PMID 41744081, PMID 42340058

NIH funding

2008 (1)